BIOVIAN OY

The article compares the manufacture of viral vectors with that of recombinant proteins and reveals how Biovian has developed a solution to...

Biovian has signed an agreement with a European biopharmaceutical company for contract development and manufacturing of a COVID-19 vaccine. The...

Biovian is looking forward to discussing joint efforts against COVID-19. Let's meet online at https://virtual-partnering.com/

A conversation with Pirjo Merilahti, PhD., Virology. At Biovian, Viral Vector process development is planned and executed by a team of...

Biovian has expanded GMP QC laboratory facilities.
Biovian has expanded its GMP QC laboratory facilities by 708 m2 to increase analytical...

European Biotechnology, the life science and industry magazine has published their spring issue with a bioprocessing special, focusing in vector...

News Biovian has expanded its GMP Viral Vector contract development and manufacturing facilities to tackle the bottleneck in Viral Vector...

Keensight Capital, one of the leading players in Growth Private Equity, announced the acquisition of a majority stake in Biovian, a leading...

Take Advantage of One-on-One Partnering! Schedule a virtual meeting with Magnus Gustafsson, the Head of Global Business Development of Biovian...

News Biovian continues to closely monitor COVID-19 related guidelines and mandates issued by various local, national and international...